The organ shortage is the major challenge facing the field of solid organ transplantation. There are multiple causative factors reported related to donors, recipients, OPOs, regulatory issues, logistics, and even days of the week as contributory to lowering organ transplant rates.
organs. Deceased donors comprise two-thirds of kidneys available for transplant, yet in 2016, the rate of kidney discard continued to increase totaling 3629 of 18 132 kidneys procured (20.0%). 2, 3 While many of these kidneys were not suitable for transplantation, many of these organs would benefit well-selected recipients. 4 Commonly cited reasons for kidney discards include poor organ quality (eg, higher Kidney Donor Profile Index (KDPI), abnormal biopsy findings, prolonged cold ischemic time, anatomy), punitive regulatory and payer sanctions due to poor clinical outcomes, and the increased cost associated with the use of higher KDPI organs. [4] [5] [6] Discard rates also vary based upon geography, suggesting that much of this variation is behavioral or loosely based upon the subjective "sense" of organ viability by the transplant team. 5, 8 Under the direction of the National Kidney Foundation's Transplant Task Force, a Consensus Conference on Decreasing
Kidney Discards was convened on May 18-19, 2017 . The NKF invited a steering committee consisting of a diverse group of transplant professionals (Table S1 ). The steering committee divided into three workgroups (Table 1) , inviting additional opinion leaders, who met monthly by conference call starting 19
January 2017, until the meeting. These multidisciplinary workgroups reviewed the literature and sought to develop a list of actionable solutions to increase organ utilization. Workgroup members assembled in Baltimore, MD (Table S2) for 1½ days of meetings. Table 2 describes the stakeholder groups participating in the conference. Scribes from each group recorded the discussion and recommendations. The workgroup chairs were responsible for presenting a summary of the workgroup findings on the last day of the meeting, and conveying these findings in this white paper. This report describes the main results of this National Consensus Conference to Decrease Kidney Discards. Tables 3 and 4 .
A summary of the conference recommendations is presented in

| ORG AN PRO CUREMENT ORG ANIZ ATI ON INTERVENTI ON S TO REDUCE ORG AN DISC ARD
| Adopt a systems approach to increasing kidney utilization
Effective OPO collaboration with local transplant programs can increase local organ utilization and improve outcomes. 9 By working together as a part of the QAPI process, innovative approaches can be developed to reduce discards. An example of this is holding routine in-person meetings to review utilization data and develop action plans for increasing use of locally recovered kidneys, within the DSA. For kidneys that are discarded or exported out of the DSA, root cause analyses on selected cases can identify areas to be improved upon by pinpointing failure points in the processes of organ recovery, allocation, and delivery to the transplant center.
In an effort to improve utilization of kidneys at risk of dis- 
| OPO practices to increase utilization within the current kidney allocation system
The current system of kidney allocation is based upon an electronic communication platform that limits verbal interactions. Efforts should be undertaken to improve dialog between OPO and transplant center personnel in parallel with DonorNet.
11
With the increase in transported kidneys (30% up from a his- When an OPO transports a kidney outside of its region based on allocation policy, allowing "local backup" should be made mandatory to reduce cold ischemic time if the intended recipient is not compatible after physical crossmatch. Cold ischemic times are shown to be significantly less when the backup recipient is in the receiving DSA, versus returning the kidney to the host OPO for reallocation.
14 Likewise, when accepting an import offer, including a combined transplant (ie, simultaneous pancreas kidney transplant), the receiving center should have a medically cleared recipient on standby should the decision be made to keep the organ at the center, versus reallocation within the receiving DSA. Finally, to extend viable cold ischemic time of a shipped kidney, host OPOs should make a routine practice of shipping kidneys on a perfusion pump rather than static cold storage.
| FINAN CIAL BARRIER S CONTRIBUTING TO ORG AN D ISC ARD
| Economic disincentives contribute to kidney discard and need to be resolved
Kidney transplantation in patients with high-quality organs is Among the perceived barriers to wider use of these organs is the significant increased cost of the transplant episode, higher rates of early complications, and decreased allograft survival resulting in a higher rate of return to dialysis.
16-18
The increasing age and burden of comorbidity of recipients increase the cost of a kidney transplant. 19 Analysis of hospital cost data suggests that the cost of transplant is strongly tied to the candidate estimate post-transplant survival (EPTS) score.
16
Deceased donor kidney transplant in patients with EPTS scores of 85-100 (shorter expected survival) was associated with $5257 more in costs but only $2475 of additional Medicare payments.
Additionally, these candidates are typically offered high KDPI
TA B L E 4 Discard Conference research priorities
Research Priority Rationale
Collect specific granular data on reasons for organ refusal Current system only records broad categories for organ refusal. Better data can inform system changes to improve organ utilization Perform a randomized trial of renal biopsy use in organ procurement and acceptance Current widespread use of biopsy is potentially contributes to the refusal of organs that may provide acceptable patient outcomes.
Understanding the role of kidney biopsies in the evaluation of organ quality and impact on allocation/acceptance Quality of kidney biopsies is highly variably and not standardized. How these results are used in evaluation and organ acceptance need to be better understood to move them from tools for ruling in rather that ruling out organs.
Fund research into organ procurement methodology
Organ procurement methods have not significantly changed for decades Improve the current regulatory framework for quality metrics that transplant centers are measured against Improved understanding of how the current transplant center metrics are impacting should inform the development of the next set of metrics
Test the effect of exempting higher risk organs from regulatory oversight on transplant center acceptance behavior
Demonstrate that decrease in regulatory oversight will lead to increased organ utilization without significant decrease in patient outcomes
Perform a cost-benefit analysis to look at the value of using higher risk organs
Quantification of cost savings of utilizing high-risk organs, compared with continuing dialysis, may incentive increased organ utilization and differential reimbursement organs and the challenges of using these higher risk kidneys further compounds expected losses.
Technological interventions may mitigate some of the delayed graft function associated with high KDPI organs and lower the cost of these transplants. 20 A retrospective analysis of Medicare-insured recipients demonstrated that machine pulsatile perfusion as compared to static cold preservation reduced Medicare payments by $2131 per organ, 19 totaling more than $17.5 million in direct expenses saved. Although the summation of these costs cannot be fully accrued on the Medicare cost report, the economics often favor machine perfusion. Additionally, a multicenter study found perfusing kidneys reduced the cost of transplant by $2039 per case (P < 0.0001). 16 Broader application of these technologies may lead centers to utilize these kidneys, reducing the cost of the transplant.
Finally, the development of risk-adjusted payment systems is needed to ensure that organs that are clinically and economically beneficial in the long term are not declined due to the financial challenges in the short term (see below).
| Increasing value and developing new payment models
Value is loosely defined by an equation of quality divided by cost. 21 In kidney transplantation, the numerator consists of outcome parameters such as graft or patient survival, quality of life, and months of dialysis avoided divided by a denominator of aggregate cost.
Because transplantation saves money when compared to long-term dialysis, payers should support efforts to increase the pool of available transplantable organs. 22, 23 Changes in the practices of payers could result in a decreased rate of discard of deceased donor organs.
These changes would require payers to support transplant centers through reimbursement of the additional cost accrued when accepting higher risk organs. The major challenge to this approach is deciding upon a fair method of apportioning costs and sharing profits. It is generally accepted that patient outcomes are improved by transplantation with marginal organs. 24, 25 However, a large volume, costbenefit analytic study is needed to account of the aggregate cost, and to prove the value, of a kidney transplant utilizing these organs.
| EFFEC T OF THE REG UL ATORY ENVIRONMENT ON KIDNE Y DISC ARD
The current regulatory environment may impact the kidney discard rate by increasing risk aversion on the part of transplant centers. 26, 27 Transplant centers are held accountable for one-year graft and patient survivals, and there are concerns regarding how the use of high KDPI kidneys, or those with long cold ischemic times, will impact center ratings. Empirical evidence indicates that poor center performance ratings are associated with a decline in transplant volume. 28, 29 This effect persists despite analyses demonstrating that donor factors are adequately captured in the risk adjustment models. 30 Overcoming the concern of the influence of donor risk on center outcomes will New criteria for rating transplant centers should incorporate the potentially reduced graft survival of higher risk donor kidneys;
this would remove the current disincentives that exist to use these kidneys. 31 The development of more comprehensive metrics may improve alignment of transplant center and patient incentives and increase organ utilization. This approach would benefit older patients who through accepting higher risk kidneys could experience shorter waiting times, or avoid dialysis through preemptive transplantation. Additionally, society would benefit through an overall reduction in health care costs.
| TR AN S PL ANT CENTER FAC TOR S TO REDUCE D ISC ARDS
| Waitlist management
For an approach that promotes the utilization of marginal organs to be successful, it requires that waitlist patients are suitably prepared to receive the transplant at the time of an offer. 32 At the time of listing, current practice requires that all patients "consent" to be listed for offers, and hence receive a varied "menu" of possible organs from deceased donors. It is extremely difficult and often stressful for patients to weigh these options against the alternative of remaining on dialysis. Therefore, at the time of reevaluation, it is important to review the different types of organ offers the patient may receive. Additionally, the mandated language of the consent process for PHS increased risk kidneys may be a source of patient anxiety and misunderstanding. Candidates require education that a decision not to list for such kidneys may exclude them from offers that may benefit them. 
| Decision support for accepting physician
| SYS TEM -LE VEL CHANG E S TO REDUCE ORG AN DISC ARD
| Expedited placement of high-risk kidneys
Kidney allocation can be a time-consuming process, especially for donor kidneys with a high KDPI. Although many centers universally "opt in"
for all patients on their waitlist when setting donor organ acceptance criteria, many centers when faced with a high KDPI offer repeatedly
decline (Organ Procurement and Tranplantation Network [OPTN] data).
Placement of a high KDPI kidney should be offered to programs that have a track record of acceptance. Utilization of high KDPI and other high-risk kidneys requires getting the right kidney to the right patient who is optimized and able to accept the organ at the right time. 34, 35 This requires new strategies for allocating organs. One approach is to develop an expedited pathway for organs assessed at risk of discard as currently done in the United Kingdom and Europe. 35 Briefly, after five centers have declined a kidney, a fast-track kidney allocation scheme is employed in which all centers have 45 minutes to review donor data and document an electronic acceptance. The kidney is immediately allocated to the highest ranking center based upon the allocation algorithm. This approach is similar to that proposed for the allocation of livers. 36 This will require participating transplant centers to combine both aggressive acceptance behaviors and maintain the expertise to successfully complete the transplant; this may be a minority of transplant programs. In this model, the transplant center and not the individual patient would drive the allocation. The kidney would be given to the center that has the best chance for using it. Of note, such a systems-level change in organ allocation would require a change in policy. Currently, an OPO Subcommittee, the Expedited Placement Workgroup, is working on a proposal to change allocation policy to allow this approach.
An alternative approach would be to identify organs at risk of discard in the traditional pathway. When timing is vital, and the standard allocation prioritization has not been successful, the default should be program-directed allocation to salvage the opportunity for utilization. A set of defined parameters such as time post-cross-clamp or number of offers refused could trigger a suspension of normal allocation, and the kidney allocated to the most proximal aggressive center. This would be similar to the European Seniors Programs in Eurotransplant. 34 There would still be defined rules for this rescue allocation pathway, and allocation should still be to a patient and not a center. A scorecard could be developed for each program predicting the likelihood of acceptance of high KDPI kidney offers. High KDPI kidneys could be directed to patients in centers most likely to accept such offers. Transplant programs that rarely accept these offers would not have access to high KDPI offers, allowing for more expeditious allocation progression and improved organ utilization.
Periodically, however, a center would be granted the chance to "opt in" to this allocation sequence with the opportunity to gain experience with these organs. With greater use, a transplant center could progressively increase the likelihood of receiving these offers.
| ORG AN QUALIT Y
| The need for a prospective trial of routine procurement biopsies
The most common reason documented by OPOs for discarding a kidney is the procurement biopsy interpretation. 1, 4, 6 In a publication in 1995, 65 transplant recipients (49 deceased donors) had a wedge implantation biopsy with at least 10 glomeruli 65/85 (76%).
37
Graft loss occurred in 4/57 (7%) of recipients of kidneys with <20% glomerulosclerosis and 3/8 (38%) with ≥20% glomerulosclerosis (P < 0.04). This single study is frequently cited as a reason to obtain procurement biopsies and to decline kidneys with ≥20% glomerulosclerosis. Many studies subsequently found limited or no association between biopsy results and graft survival, and concluded that routine procurement biopsies alone should not be used to reject deceased donor kidneys for transplant. [38] [39] [40] Other studies have described the limitations of the frozen section, particularly in the hands of inexperienced pathologists. 41 Procurement biopsies are not routinely used in Europe 42 ; however, in the United States, routine procurement biopsies are still used to decline kidney transplants that have net transplant benefit.
This discordance between evidence and practice creates a compelling need for a prospective controlled trial to understand the benefits and harms of using routine biopsy results in kidney offer acceptance decisions. This proposed trial will preferably ensure standardization of biopsy types (cores rather than wedges), uses pathologist with renal-specific training along with the introduction of technology to eliminate interobserver variation such as slide imaging. While it is definitely possible that no pathologic biopsy findings would be robust enough to include in an algorithm for discard, biopsy findings may have a potential role in some very specific settings such as attempting to distinguish acute dysfunction from chronic scarring. As a result, biopsy findings may potentially help "rule in" rather than "rule out" organs for transplantation, and this may help centers transition to a period of lower reliance on kidney biopsies prior to transplantation.
| Presentation of the allograft
Another factor discussed in the assessment of organ quality is the variability in the preparation of allografts and use of gross photographs provided to transplant centers. While some OPOs routinely provide a gross photograph, others do not. Even when gross anatomy images are available, there is a wide range of quality in the images provided to clinicians. Efforts are needed to educate procurement teams of the necessity of highlighting vasculature and providing in-focus images including a ruler to help provide scale.
Improved imaging of these organs could help to increase acceptance. To standardize practices across OPOs, consideration should be given to making posting of a gross photograph on DonorNet mandatory.
| D ISC ARD RE S E ARCH
A major impediment in efforts to decrease the discard rate is the limitations in the data being captured on discarded organs; more granular data on the true reasons for organ refusal are urgently needed. 43 For instance, the causes for unilateral discards are not understood, where it is unlikely that donor factors were the primary reason. 6 Collection of such data will require coordinated efforts between transplant centers, OPOs, and UNOS. Improved data collection will inform efforts to estimate organ quality more reliably and thereby allow for more appropriate organ utilization/allocation and potentially reduce discards.
In addition to improving the data collection efforts, reducing the discard of kidneys will require the development of significant research in 3 broad categories (Figure 1 ). Current research opportunities may also be found in normothermic ex-vivo perfusion and regenerative medicine to recondition organs from older donors or those with long cold ischemia time. 
| Optimizing kidney recovery and management
| Identification and testing opportunities to improve allocation of organs
Improved allocation of kidneys, especially those that are hard to place, would include studying/identifying opportunities within the framework of the current allocation system for improved efficiencies, and potential modifications that change how and potentially to whom these organs are allocated. In addition, developing an understanding of the financial and regulatory imperatives that influence the decision to either accept or decline an organ offer is critical to the development of financial models that may encourage appropriate use of these organs. This would also include the development of efforts to identify individuals most likely to benefit from accepting these organs.
Research to facilitate early organ acceptance includes the following:
optimizing organ offer characterization, understanding and abrogating the impact of oversight on impeding liberalized acceptance, testing interventions to ameliorate graft dysfunction, identifying methods to increase value with the use of high risk for discard kidneys, and developing enhanced waitlist management. A paucity of research F I G U R E 1 Key areas for potential future research exists covering informational factors that impede placement such as clarity of organ damage or anatomic issues, or access to specialists (ie, infectious disease consultants). As previously mentioned, variation in acceptance rates of kidneys between centers and surgeons indicates ineffective allocation, and discard of some acceptable kidneys. 26 Improved waitlist management is another important step in the process of improving organ allocation efficiency. In some cases, candidate availability affects discard such as with organ offers from donors that are HCV+, HBV+, HIV+, and AB blood type. Therefore, research that promotes waitlist maintenance or allows safe transplantation of these organs into virus negative candidates is required.
A greater understanding and support of the complex decisionmaking process, including the impact of current regulatory oversight, that occurs with an organ offer is urgently needed. This includes the development of improved, standardized, and streamlined communication strategies between OPOs and transplant centers. The impact of feeding back outcomes for organs that were declined by centers and successfully transplanted elsewhere has been proposed as one way to educate and discourage the inappropriate refusal of organs.
The potential to improve organ acceptance by engaging nephrologists to help with recipient selection, to explain the benefits of a high-risk organ to a potential recipient, and to share the responsibility for organ acceptance should be investigated.
| EDUC ATION
The development of new and innovative educational initiatives may potentially improve organ utilization. PHS-IR donors may be one category of organs that may be underutilized based on misperceptions of actual risk or effective dissemination of benefits of these organs. Studies have shown that while kidney transplant outcomes from PHS-IR donors are similar to non-PHS-IR donors, they remain overall underutilized. 47 Additionally, there is a belief by patients that kidneys from PHS-IR donors suffer from lower quality and poorer outcomes. Moreover, the lack of familiarity by providers with definitions and evidence-based estimates of risk has been previously found to be particularly important barriers to organ utilization. [48] [49] [50] In general, enhancing organ utilization decisions may require an improved understanding of the outcomes associated with select donor characteristics by both patients and providers. In instances where the data already exist, such as diabetic donors and kidneys with AKI, education efforts are needed. 51, 52 For other circumstances in which there are limited data, additional research is called for. Finally, if we are to achieve sustainable changes in perception, patients must participate in research to understand reasons for the decline of kidneys, and lend their voices to efforts to improve organ utilization. 
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